Showing 9 out of 9 results
The ACCC pilots its first ‘effect test’ in misuse of market power proceedings
On 6 December 2019, the ACCC launched its first enforcement proceedings under the new ‘effects test’ prohibition on misuse of market power. The …
Comments on UK proposal for the future relationship with the EU
Last Friday, 6 July, it was understood that the UK Cabinet had finally united around a UK position on the desired future relationship with the EU. …
Pfizer beats the ACCC again – implications for pharma
The Full Court of the Federal Court of Australia has dismissed an appeal by the ACCC against an earlier judgment in relation to pharmaceutical company …
The view from Brussels – Brexit negotiations – Developments in October
The Brexit debate often looks different viewed from Brussels rather than from London. It is however important for businesses to also keep in mind the …
EU unveils proposals for toughened security screening of foreign investments
As states race to usher in tighter security controls on foreign takeovers, we assess the EU's new framework for screening FDIOn 13 September 2017 the EU …
ACCC v Medibank Private Limited: Court finds no misrepresentation in regards to out-of-pocket medical expenses
The Federal Court has found against the ACCC in considering changes to Medibank’s coverage for certain out-of-pocket expenses and related representations …
Frictionless trade? UK-EU customs relations post-Brexit
On 15 and 16 August 2017 the UK Government published two papers setting out its proposals for UK-EU customs relations post-Brexit. While these …
Regulatory reform to the advertising of medicines and medical devices
The Australian Government has announced that the regulation of medicines and medical devices advertising is to be changed. Given recent examples of …
Class action growth continues as 25th anniversary looms
The next 12 months will cement Australia as the second most active class action market in the world, behind only the US. This is being driven by: new …
Showing 9 out of 9 results